Mark has been a Lecturer in the School of Law since January 2017. He holds an LLB (Hons)(2009) from the University of Wales, Aberystwyth, an LLM in Medical Law and Ethics (2011) from the University of Edinburgh, and a PhD (2016) from the University of Manchester entitled: “The Right to Health and Access to Pandemic Influenza Vaccines: Procurement Options for Developing States”, which was funded by a scholarship award from the University of Manchester.
Prior to joining Keele, Mark was a Lecturer of Law at Birmingham City University and a Graduate Teaching Assistant at the University of Manchester,
Mark also serves as a Consultant to the World Health Organization Working Group on Pandemic Influenza Vaccine Supply Hubs.
Mark welcome PhD proposals in the field of Global Health Law.
Research and scholarship
Mark’s research is in Global Health Law, particularly influenza vaccines, pandemic response and management, and the law of international organisations in the context of global health - through this Mark’s work touches upon intellectual property law, public international law, and the law of international organisations.
He has published widely in Global Health Law, and is currently authoring a monograph entitled “could you patent the sun? Intellectual property rights and access to pandemic influenza vaccines.”
Controversies in Intellectual Property Law
Mark teaches across a number of postgraduate, including: Advanced International Law; Health, Justice and Society; Life, Death, and the Human Body, and Dissertation.
Mark leads the Global Health Law module on the International Law Masters programme.
Awarded a visiting researcher fellowship at Fondation Brocher, Geneva in summer 2017.
Awarded a 3 year Graduate Teaching Assistant scholarship from the University of Manchester.
- ‘Access to scientific knowledge, intellectual property, and the public good’ Society of Legal Scholars Annual Conference, Oxford (2016)
- ‘The Economic Theory of Patent Protection and Pandemic Influenza Vaccines: Do Patents Really Incentivise Innovation?’ American Journal of Law & Medicine Symposium, Boston, M.A (2016)
- ‘Incentivising Innovation During a Pandemic: What role for Intellectual Property?’ Global Congress on Intellectual Property and the Public Good, New Delhi (2015)
- ‘The Economic Theory of Patent Protection and Pandemic Influenza Vaccines: Do Patents Really Incentivise Innovation?’ University of Copenhagen Postgraduate Law Conference (2015)
- ‘The TRIPS Agreement and Access to Pandemic Influenza Vaccines: An Analysis of the Patent Flexibilities and Transfer of Technology Provisions’, International Graduate Legal Research Conference, London (2014)
- ‘The Role of Advance Purchase Agreements in Access to Pandemic Influenza Vaccines During 2009-H1N1’, University of Manchester Postgraduate Research Conference, Manchester (2014)
- ‘Solidarity as an Overarching Bioethical Principle during a Pandemic: A Case Study Analysis’, The Consortium of Universities for Global Health Conference, Washington D.C (2013)
Full Publications List show
Preparing for the Next Pandemic — The WHO’s Global Influenza Strategy. New England Journal of Medicine, vol. 381(23), 2192-2194. doi>2019.
Inter-Institutional Relationships in Global Health: Regulating Coordination and Ensuring Accountability. Global Health Governance. full text>2018.
Operationalizing the Right to Health through the Pandemic Influenza Preparedness Framework. Global Health Governance, vol. XII(1), 22-34. full text>2018.
Accountability, international law, and the World Health Organization: A need for reform?. Global Health Governance, vol. XI(1), 27-40.2017.
The Economic Theory of Patent Protection and Pandemic Influenza Vaccines Do Patents Really Incentivize Innovation in the Field?. American Journal of Law and Medicine -Boston-, vol. 42(2), 572-597. doi>2016.
The global governance of HIV/AIDS: Intellectual property and access to essential medicines. Global Public Health, vol. 9(9), 1117-1118. doi>2015.